Works matching IS 13960296 AND DT 2025 AND VI 2025 AND IP 1

Efficacy and Safety of GR1802 in Patients With Moderate‐to‐Severe Atopic Dermatitis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Phase 2 Trial.

Published in:

Dermatologic Therapy, 2025, v. 2025, n. 1, p. 1, doi. 10.1155/dth/6903760

By:

• Wang, Shangshang;
• Zhang, Litao;
• Liang, Yunsheng;
• Zhang, Shifa;
• Wang, Jingyan;
• Man, Xiaoyong;
• Ji, Chao;
• Chen, Rixin;
• Xiang, Guang;
• Meng, Zudong;
• Yang, Chunjun;
• Cheng, Hao;
• Wang, Qi;
• Li, Lin-feng;
• Zhang, Siping;
• Ding, Yanfeng;
• Zhu, Quangang;
• Qin, Lanying;
• Li, Yumei;
• Lu, Qianjin

Publication type:

Article